Abstract
Overactive bladder (OAB) with urinary incontinence poses a potentially significant impact on daily activities and quality of life. Due to its successful outcomes in the treatment of neurogenic bladder, intravesical botulinum‑A toxin (BTX-A) became a possible solution for children refractory to treatment. 50 children (41 boys) with a median age of 9.9 years were included. In
... read more